JANICE HEDAYATI: Open Payments
NPI 1861648065 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 64 payments from 10 companies in 2025. Trend: 2023 $1,373 · 2024 $1,171 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $244 |
| Phathom Pharmaceuticals, Inc. | 14 | $191 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $143 |
| Aimmune Therapeutics, Inc. | 4 | $92 |
| Ardelyx, Inc. | 4 | $74 |
| GENZYME CORPORATION | 4 | $72 |
| PFIZER INC. | 4 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Valinor Pharma, LLC | 2 | $28 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $17 |
Products named: RINVOQ, VOQUEZNA, XIFAXAN, VOWST, IBSRELA, DUPIXENT, XELJANZ, MOVANTIK.
Industry payments across KY — which companies pay providers there.
